share_log

Benchmark Reiterates Buy on Beauty Health, Maintains $23 Price Target

Benzinga ·  Sep 13, 2023 20:20

Benchmark analyst Bruce Jackson reiterates Beauty Health (NASDAQ:SKIN) with a Buy and maintains $23 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment